Substitution on the Phe3 aromatic ring in cyclic .delta. opioid receptor-selective dermorphin/deltorphin tetrapeptide analogs: electronic and lipophilic requirements for receptor affinity

Journal of Medicinal Chemistry
1992.0

Abstract

In an effort to explore structural features affecting receptor recognition in a series of conformationally restricted tetrapeptides related to the cyclic, delta opioid receptor-selective analogue, [formula: see text] electronic, lipophilic, and steric effects at the Phe3 residue were assessed by substitution at different positions of the side-chain aromatic ring by halogens, alkyl, hydroxyl, and nitro groups. Effects on opioid receptor binding affinity and selectivity were determined. The results, which are generally consistent with reports of analogous modifications in linear and cyclic pentapeptide enkephalins, indicate that steric, lipophilic, and electronic properties are all important determinants of delta opioid receptor recognition. Specifically, modifications which increase lipophilicity or exert electron-withdrawing effects on the aromatic ring enhance binding affinity, while hydrophilic, bulky, or electron-releasing modifications are detrimental. These observations are in excellent agreement with quantitative structure-activity relationship (QSAR) results reported for Phe4 modifications in linear opioid pentapeptide enkephalin analogues, suggesting that the Phe3 tetrapeptide side chain and the Phe4 pentapeptide side chain interact with the same delta receptor binding subsite.

Knowledge Graph

Similar Paper

Substitution on the Phe3 aromatic ring in cyclic .delta. opioid receptor-selective dermorphin/deltorphin tetrapeptide analogs: electronic and lipophilic requirements for receptor affinity
Journal of Medicinal Chemistry 1992.0
Phe3-substituted analogs of deltorphin C. Spatial conformation and topography of the aromatic ring in peptide recognition by .delta. opioid receptors
Journal of Medicinal Chemistry 1993.0
Opioid Receptor Binding Requirements for the .delta.-Selective Peptide Deltorphin I: Phe3 Replacement with Ring-Substituted and Heterocyclic Amino Acids
Journal of Medicinal Chemistry 1995.0
Design and Synthesis of 1-Aminocycloalkane-1-carboxylic Acid-Substituted Deltorphin Analogues:  Unique δ and μ Opioid Activity in Modified Peptides
Journal of Medicinal Chemistry 1996.0
Para-substituted Phe3 deltorphin analogs: enhanced selectivity of halogenated derivatives for .sigma. opioid receptor sites
Journal of Medicinal Chemistry 1992.0
Dermorphin and deltorphin heptapeptide analogues: replacement of Phe residue by Dmp greatly improves opioid receptor affinity and selectivity
Bioorganic & Medicinal Chemistry Letters 2002.0
Dermorphin sequence with high δ-afinity by fixing the phe sidechain to trans at ξ1
Bioorganic & Medicinal Chemistry Letters 1992.0
Design of cyclic deltorphins and dermenkephalins with a disulfide bridge leads to analogs with high selectivity for .delta.-opioid receptors
Journal of Medicinal Chemistry 1994.0
Ring substituted and other conformationally constrained tyrosine analogs of [cyclic] [D-Pen2,D-Pen5]enkephalin with .delta.-opioid receptor selectivity
Journal of Medicinal Chemistry 1992.0
Differential receptor binding characteristics of consecutive phenylalanines in μ-opioid specific peptide ligand endomorphin-2
Bioorganic & Medicinal Chemistry 2007.0